Antiverse, a biotechnology company developing a computational antibody drug discovery platform, has raised seed funding totalling £1.4 million ($2 million USD), comprising new investment and match funding from the UKI2S Innovate Accelerator. The funding will be used to further develop Antiverse’s AI antibody drug discovery platform,...
Cambridge Angels is a leading UK business angel network with international connections.
We are a collaborative Cambridge-based group, actively mentoring and investing in innovative entrepreneurial teams and their ideas, to achieve returns and help realise their full potential. We have a strong ethos of backing merit and supporting entrepreneurship.
Our members, most of whom are successful entrepreneurs, invest in a wide range of start-up and scale-up businesses with a particular focus on technology, internet, software, hardware, and tools and technologies supporting healthcare.